Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pituitary Neoplasms | 31 | 2024 | 1324 | 5.910 |
Why?
|
Neurosurgical Procedures | 46 | 2024 | 2072 | 5.290 |
Why?
|
Craniotomy | 30 | 2022 | 741 | 4.720 |
Why?
|
Brain Neoplasms | 51 | 2024 | 9031 | 3.850 |
Why?
|
Rhinitis | 19 | 2018 | 747 | 3.790 |
Why?
|
Sinusitis | 19 | 2018 | 991 | 3.420 |
Why?
|
Defensive Medicine | 6 | 2017 | 47 | 3.180 |
Why?
|
Endoscopy | 24 | 2024 | 1851 | 2.950 |
Why?
|
Neurosurgery | 12 | 2022 | 679 | 2.860 |
Why?
|
Paranasal Sinuses | 9 | 2019 | 265 | 2.350 |
Why?
|
Adenoma | 19 | 2024 | 2163 | 2.280 |
Why?
|
Postoperative Complications | 49 | 2024 | 15633 | 2.240 |
Why?
|
Spinal Diseases | 7 | 2023 | 564 | 2.010 |
Why?
|
Venous Thromboembolism | 16 | 2022 | 1866 | 1.940 |
Why?
|
Prolactinoma | 5 | 2024 | 114 | 1.860 |
Why?
|
Glioma | 16 | 2024 | 3455 | 1.500 |
Why?
|
Malpractice | 7 | 2023 | 556 | 1.470 |
Why?
|
Skull | 6 | 2022 | 818 | 1.300 |
Why?
|
Granular Cell Tumor | 2 | 2019 | 48 | 1.240 |
Why?
|
Craniopharyngioma | 3 | 2021 | 277 | 1.070 |
Why?
|
Glioblastoma | 13 | 2023 | 3482 | 1.060 |
Why?
|
Microsurgery | 5 | 2022 | 795 | 1.050 |
Why?
|
Nasal Cavity | 4 | 2016 | 304 | 1.030 |
Why?
|
Neuroendoscopy | 5 | 2024 | 99 | 1.010 |
Why?
|
Intracranial Aneurysm | 8 | 2019 | 1285 | 1.000 |
Why?
|
Sella Turcica | 4 | 2024 | 118 | 0.950 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 4 | 2023 | 63 | 0.930 |
Why?
|
Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 13 | 0.930 |
Why?
|
Prolactin | 4 | 2024 | 625 | 0.920 |
Why?
|
Spinal Fusion | 12 | 2021 | 1286 | 0.910 |
Why?
|
Patient Readmission | 16 | 2020 | 3271 | 0.910 |
Why?
|
Decompressive Craniectomy | 2 | 2022 | 76 | 0.900 |
Why?
|
Spinal Neoplasms | 3 | 2020 | 716 | 0.880 |
Why?
|
Quality Improvement | 19 | 2020 | 3801 | 0.870 |
Why?
|
Nasal Obstruction | 2 | 2016 | 160 | 0.870 |
Why?
|
Spine | 9 | 2023 | 1118 | 0.860 |
Why?
|
Humans | 249 | 2024 | 761578 | 0.860 |
Why?
|
Antibiotic Prophylaxis | 3 | 2017 | 637 | 0.860 |
Why?
|
Skull Base Neoplasms | 5 | 2020 | 270 | 0.850 |
Why?
|
Meningioma | 7 | 2023 | 1218 | 0.840 |
Why?
|
Acromegaly | 2 | 2024 | 310 | 0.830 |
Why?
|
Olfaction Disorders | 2 | 2015 | 224 | 0.820 |
Why?
|
Middle Aged | 122 | 2024 | 220917 | 0.820 |
Why?
|
Insurance, Liability | 3 | 2017 | 101 | 0.810 |
Why?
|
Adult | 116 | 2024 | 221200 | 0.800 |
Why?
|
Human Growth Hormone | 2 | 2017 | 642 | 0.780 |
Why?
|
Pulmonary Embolism | 6 | 2022 | 2567 | 0.780 |
Why?
|
Retrospective Studies | 78 | 2024 | 80646 | 0.770 |
Why?
|
Female | 152 | 2024 | 392688 | 0.770 |
Why?
|
Sphenoid Bone | 7 | 2024 | 177 | 0.760 |
Why?
|
Surgical Wound Infection | 6 | 2018 | 1529 | 0.760 |
Why?
|
Male | 146 | 2024 | 360841 | 0.760 |
Why?
|
Hormone Replacement Therapy | 2 | 2017 | 751 | 0.750 |
Why?
|
Tumor Burden | 3 | 2024 | 1893 | 0.740 |
Why?
|
Facial Pain | 2 | 2014 | 120 | 0.720 |
Why?
|
Aged | 91 | 2024 | 169308 | 0.710 |
Why?
|
Central Nervous System Cysts | 2 | 2018 | 56 | 0.710 |
Why?
|
Treatment Outcome | 62 | 2024 | 64684 | 0.700 |
Why?
|
Reoperation | 13 | 2019 | 4303 | 0.690 |
Why?
|
Cranial Nerve Neoplasms | 2 | 2018 | 134 | 0.690 |
Why?
|
Venous Thrombosis | 4 | 2022 | 1303 | 0.680 |
Why?
|
Eccrine Glands | 1 | 2020 | 52 | 0.680 |
Why?
|
Meningeal Neoplasms | 6 | 2023 | 1248 | 0.670 |
Why?
|
Databases, Factual | 13 | 2023 | 7967 | 0.670 |
Why?
|
Neoplasm Recurrence, Local | 13 | 2024 | 9281 | 0.660 |
Why?
|
Cranial Irradiation | 2 | 2019 | 390 | 0.650 |
Why?
|
Skull Neoplasms | 1 | 2020 | 173 | 0.640 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2021 | 258 | 0.630 |
Why?
|
Cadaver | 1 | 2022 | 1358 | 0.620 |
Why?
|
Natural Orifice Endoscopic Surgery | 2 | 2019 | 119 | 0.610 |
Why?
|
Sweat Gland Neoplasms | 1 | 2020 | 116 | 0.610 |
Why?
|
Postoperative Period | 9 | 2021 | 1814 | 0.600 |
Why?
|
Endovascular Procedures | 5 | 2019 | 2183 | 0.590 |
Why?
|
Chordoma | 2 | 2018 | 347 | 0.590 |
Why?
|
Headache | 3 | 2018 | 1256 | 0.580 |
Why?
|
Aged, 80 and over | 44 | 2024 | 58983 | 0.580 |
Why?
|
Middle Cerebral Artery | 2 | 2017 | 275 | 0.580 |
Why?
|
Anticoagulants | 8 | 2024 | 4812 | 0.570 |
Why?
|
Quality of Life | 16 | 2023 | 13367 | 0.560 |
Why?
|
Chronic Disease | 18 | 2018 | 9319 | 0.560 |
Why?
|
Pituitary ACTH Hypersecretion | 2 | 2021 | 179 | 0.560 |
Why?
|
Radiosurgery | 5 | 2022 | 1342 | 0.550 |
Why?
|
Exercise Therapy | 1 | 2023 | 929 | 0.550 |
Why?
|
SEER Program | 3 | 2019 | 1450 | 0.540 |
Why?
|
Anticonvulsants | 5 | 2024 | 1906 | 0.520 |
Why?
|
Cavernous Sinus | 1 | 2017 | 123 | 0.520 |
Why?
|
Surgical Flaps | 2 | 2022 | 1671 | 0.520 |
Why?
|
Aneurysm | 1 | 2019 | 337 | 0.520 |
Why?
|
Sphenoid Sinus | 6 | 2018 | 99 | 0.520 |
Why?
|
Valproic Acid | 1 | 2018 | 443 | 0.510 |
Why?
|
Young Adult | 46 | 2024 | 59254 | 0.510 |
Why?
|
Nose | 4 | 2016 | 521 | 0.510 |
Why?
|
Prognosis | 26 | 2023 | 29629 | 0.500 |
Why?
|
Radiculopathy | 2 | 2021 | 202 | 0.500 |
Why?
|
Ependyma | 1 | 2015 | 56 | 0.500 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 238 | 0.500 |
Why?
|
Follow-Up Studies | 27 | 2023 | 39107 | 0.490 |
Why?
|
Surgery, Computer-Assisted | 2 | 2024 | 1007 | 0.490 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 2 | 2008 | 324 | 0.480 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2017 | 343 | 0.480 |
Why?
|
Frontal Sinus | 1 | 2014 | 51 | 0.470 |
Why?
|
Pituitary Diseases | 3 | 2022 | 135 | 0.470 |
Why?
|
Dopamine Agonists | 2 | 2023 | 352 | 0.460 |
Why?
|
Nose Neoplasms | 1 | 2016 | 249 | 0.460 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2018 | 328 | 0.450 |
Why?
|
Neuroma, Acoustic | 3 | 2024 | 459 | 0.450 |
Why?
|
Meningitis, Bacterial | 1 | 2016 | 221 | 0.450 |
Why?
|
Embolization, Therapeutic | 3 | 2018 | 1418 | 0.450 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2023 | 1033 | 0.440 |
Why?
|
Health Care Sector | 1 | 2015 | 195 | 0.440 |
Why?
|
Risk Factors | 39 | 2024 | 74212 | 0.430 |
Why?
|
Length of Stay | 17 | 2021 | 6426 | 0.430 |
Why?
|
Hyponatremia | 1 | 2016 | 279 | 0.430 |
Why?
|
Skull Base | 6 | 2024 | 292 | 0.430 |
Why?
|
Liability, Legal | 3 | 2023 | 210 | 0.420 |
Why?
|
Cohort Studies | 25 | 2024 | 41493 | 0.420 |
Why?
|
Meningocele | 1 | 2013 | 47 | 0.420 |
Why?
|
Neuronavigation | 1 | 2014 | 166 | 0.420 |
Why?
|
Algorithms | 6 | 2023 | 14032 | 0.420 |
Why?
|
Coma | 1 | 2016 | 484 | 0.400 |
Why?
|
Infusion Pumps, Implantable | 1 | 2013 | 158 | 0.400 |
Why?
|
Baclofen | 1 | 2013 | 120 | 0.400 |
Why?
|
Muscle Relaxants, Central | 1 | 2013 | 93 | 0.400 |
Why?
|
Carcinoma, Papillary | 1 | 2017 | 785 | 0.400 |
Why?
|
Rare Diseases | 1 | 2017 | 622 | 0.390 |
Why?
|
Sarcoma, Myeloid | 1 | 2012 | 51 | 0.390 |
Why?
|
Carotid Artery, Internal | 1 | 2014 | 445 | 0.390 |
Why?
|
Publishing | 1 | 2019 | 833 | 0.390 |
Why?
|
Stereotaxic Techniques | 1 | 2014 | 555 | 0.390 |
Why?
|
Statistics as Topic | 1 | 2017 | 2358 | 0.370 |
Why?
|
Prospective Studies | 30 | 2022 | 54423 | 0.360 |
Why?
|
Specialties, Surgical | 1 | 2015 | 389 | 0.360 |
Why?
|
Paranasal Sinus Neoplasms | 3 | 2019 | 242 | 0.360 |
Why?
|
Severity of Illness Index | 8 | 2020 | 15843 | 0.360 |
Why?
|
Survival Rate | 11 | 2020 | 12725 | 0.350 |
Why?
|
Third Ventricle | 2 | 2021 | 74 | 0.350 |
Why?
|
DNA Modification Methylases | 2 | 2021 | 210 | 0.350 |
Why?
|
Pituitary Gland | 5 | 2023 | 635 | 0.350 |
Why?
|
United States | 30 | 2023 | 72335 | 0.350 |
Why?
|
Adolescent | 41 | 2024 | 88323 | 0.350 |
Why?
|
Internal Fixators | 3 | 2021 | 183 | 0.340 |
Why?
|
Lumbar Vertebrae | 8 | 2021 | 1879 | 0.340 |
Why?
|
Diskectomy | 4 | 2021 | 209 | 0.330 |
Why?
|
Incidence | 17 | 2024 | 21355 | 0.330 |
Why?
|
Heparin | 1 | 2017 | 1634 | 0.330 |
Why?
|
Sarcoma | 1 | 2020 | 1801 | 0.330 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2020 | 10212 | 0.330 |
Why?
|
Aneurysm, Ruptured | 4 | 2019 | 464 | 0.320 |
Why?
|
DNA Repair Enzymes | 2 | 2021 | 346 | 0.320 |
Why?
|
Skin Neoplasms | 2 | 2018 | 5821 | 0.310 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.310 |
Why?
|
Patient-Centered Care | 2 | 2015 | 1421 | 0.310 |
Why?
|
Carcinoma | 1 | 2020 | 2330 | 0.310 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2013 | 625 | 0.300 |
Why?
|
Spinal Injuries | 2 | 2021 | 301 | 0.300 |
Why?
|
Multivariate Analysis | 9 | 2019 | 12059 | 0.300 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1463 | 0.300 |
Why?
|
Logistic Models | 15 | 2022 | 13255 | 0.300 |
Why?
|
Attitude of Health Personnel | 3 | 2017 | 3889 | 0.290 |
Why?
|
Respiratory Insufficiency | 1 | 2016 | 1230 | 0.290 |
Why?
|
Spinal Curvatures | 2 | 2019 | 71 | 0.290 |
Why?
|
Preoperative Care | 5 | 2021 | 2242 | 0.280 |
Why?
|
Decompression, Surgical | 4 | 2020 | 607 | 0.280 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2021 | 1784 | 0.280 |
Why?
|
Lymphoma | 1 | 2016 | 1901 | 0.280 |
Why?
|
Nasal Polyps | 2 | 2016 | 395 | 0.280 |
Why?
|
Glasgow Coma Scale | 3 | 2024 | 580 | 0.280 |
Why?
|
Fibromyalgia | 2 | 2008 | 405 | 0.270 |
Why?
|
Gastroesophageal Reflux | 1 | 2014 | 819 | 0.270 |
Why?
|
Central Nervous System Neoplasms | 3 | 2022 | 916 | 0.270 |
Why?
|
Kyphosis | 2 | 2021 | 237 | 0.270 |
Why?
|
Mobility Limitation | 2 | 2021 | 408 | 0.260 |
Why?
|
Immunotherapy | 2 | 2020 | 4651 | 0.260 |
Why?
|
Brain Abscess | 2 | 2018 | 120 | 0.260 |
Why?
|
Models, Neurological | 1 | 2014 | 1769 | 0.260 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 2 | 2018 | 87 | 0.260 |
Why?
|
Smell | 1 | 2008 | 259 | 0.260 |
Why?
|
Canada | 3 | 2016 | 2122 | 0.260 |
Why?
|
Oligodendroglioma | 2 | 2020 | 279 | 0.260 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1188 | 0.250 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2895 | 0.250 |
Why?
|
Hydrocephalus | 3 | 2021 | 764 | 0.250 |
Why?
|
Tomography, X-Ray Computed | 5 | 2024 | 20569 | 0.250 |
Why?
|
Spinal Cord Diseases | 2 | 2021 | 292 | 0.250 |
Why?
|
Steroids | 2 | 2021 | 929 | 0.240 |
Why?
|
Risk | 5 | 2017 | 9610 | 0.240 |
Why?
|
Informed Consent | 3 | 2022 | 1008 | 0.240 |
Why?
|
Surgical Instruments | 2 | 2018 | 383 | 0.230 |
Why?
|
Arachnoid | 1 | 2024 | 50 | 0.230 |
Why?
|
Stroke | 5 | 2023 | 9758 | 0.230 |
Why?
|
Predictive Value of Tests | 12 | 2021 | 15266 | 0.230 |
Why?
|
Intraoperative Complications | 2 | 2024 | 1166 | 0.230 |
Why?
|
Spinal Stenosis | 2 | 2021 | 261 | 0.230 |
Why?
|
Delivery of Health Care | 3 | 2019 | 5336 | 0.230 |
Why?
|
Astrocytoma | 2 | 2021 | 775 | 0.220 |
Why?
|
Cervical Vertebrae | 4 | 2021 | 980 | 0.220 |
Why?
|
Scoliosis | 2 | 2021 | 741 | 0.220 |
Why?
|
Low Back Pain | 1 | 2012 | 984 | 0.220 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2024 | 110 | 0.210 |
Why?
|
Survival Analysis | 5 | 2020 | 10090 | 0.210 |
Why?
|
Nervous System Diseases | 3 | 2019 | 1667 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 6 | 2020 | 6484 | 0.210 |
Why?
|
Internationality | 2 | 2018 | 1001 | 0.210 |
Why?
|
Diverticulum | 1 | 2024 | 137 | 0.210 |
Why?
|
Cognition Disorders | 1 | 2017 | 3980 | 0.210 |
Why?
|
Cerebral Angiography | 2 | 2019 | 1281 | 0.210 |
Why?
|
Age Distribution | 3 | 2017 | 2879 | 0.200 |
Why?
|
Privacy | 2 | 2022 | 233 | 0.200 |
Why?
|
Ventriculostomy | 2 | 2021 | 131 | 0.200 |
Why?
|
Registries | 11 | 2019 | 8224 | 0.200 |
Why?
|
Anti-Bacterial Agents | 6 | 2018 | 7406 | 0.200 |
Why?
|
Postoperative Hemorrhage | 2 | 2017 | 415 | 0.200 |
Why?
|
Self Report | 3 | 2019 | 3725 | 0.190 |
Why?
|
Endarterectomy, Carotid | 2 | 2019 | 555 | 0.190 |
Why?
|
Neoplasms | 6 | 2020 | 22172 | 0.190 |
Why?
|
Melanoma | 2 | 2018 | 5709 | 0.180 |
Why?
|
Bone Cements | 1 | 2022 | 325 | 0.180 |
Why?
|
Body Constitution | 1 | 2021 | 273 | 0.180 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2020 | 20 | 0.180 |
Why?
|
Natural Language Processing | 2 | 2020 | 1163 | 0.180 |
Why?
|
Comorbidity | 7 | 2019 | 10508 | 0.180 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2020 | 56 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 10 | 2021 | 36426 | 0.170 |
Why?
|
Telemedicine | 3 | 2022 | 3052 | 0.170 |
Why?
|
Brain Mapping | 2 | 2015 | 6635 | 0.170 |
Why?
|
Tinnitus | 1 | 2022 | 196 | 0.170 |
Why?
|
Alcoholic Beverages | 1 | 2021 | 264 | 0.170 |
Why?
|
Urinary Tract Infections | 2 | 2016 | 802 | 0.170 |
Why?
|
Analgesics, Opioid | 3 | 2020 | 3808 | 0.170 |
Why?
|
Bone Plates | 1 | 2022 | 466 | 0.170 |
Why?
|
Research Report | 2 | 2020 | 367 | 0.170 |
Why?
|
Carcinoma, Ductal | 1 | 2020 | 97 | 0.170 |
Why?
|
Odds Ratio | 6 | 2021 | 9646 | 0.170 |
Why?
|
Disease-Free Survival | 3 | 2023 | 6815 | 0.170 |
Why?
|
Nitriles | 1 | 2024 | 971 | 0.170 |
Why?
|
Lordosis | 2 | 2020 | 92 | 0.160 |
Why?
|
Titanium | 1 | 2022 | 485 | 0.160 |
Why?
|
Cognition | 1 | 2017 | 6992 | 0.160 |
Why?
|
Intracranial Hemorrhages | 4 | 2017 | 822 | 0.160 |
Why?
|
Pyridones | 1 | 2024 | 809 | 0.160 |
Why?
|
Geographic Information Systems | 1 | 2021 | 281 | 0.160 |
Why?
|
Time Factors | 13 | 2019 | 39970 | 0.160 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2020 | 188 | 0.160 |
Why?
|
Morals | 1 | 2022 | 289 | 0.160 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2020 | 350 | 0.160 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2018 | 40 | 0.160 |
Why?
|
Patient Discharge | 4 | 2019 | 3443 | 0.160 |
Why?
|
Abdominal Wall | 1 | 2020 | 166 | 0.150 |
Why?
|
Brachial Plexus Neuritis | 1 | 2018 | 20 | 0.150 |
Why?
|
Somatotypes | 1 | 2018 | 41 | 0.150 |
Why?
|
Health Status Indicators | 2 | 2016 | 970 | 0.150 |
Why?
|
Hematoma, Subdural | 1 | 2019 | 127 | 0.150 |
Why?
|
Research Personnel | 1 | 2023 | 588 | 0.150 |
Why?
|
Pain Measurement | 3 | 2019 | 3551 | 0.150 |
Why?
|
Speech | 1 | 2023 | 554 | 0.150 |
Why?
|
Spondylolisthesis | 1 | 2020 | 175 | 0.150 |
Why?
|
Iodide Peroxidase | 1 | 2019 | 294 | 0.150 |
Why?
|
Angiography, Digital Subtraction | 1 | 2019 | 335 | 0.150 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2020 | 638 | 0.150 |
Why?
|
Tea | 1 | 2019 | 288 | 0.150 |
Why?
|
Chondrosarcoma | 2 | 2013 | 296 | 0.140 |
Why?
|
Combined Modality Therapy | 5 | 2020 | 8528 | 0.140 |
Why?
|
Hematoma, Subdural, Chronic | 1 | 2018 | 95 | 0.140 |
Why?
|
Brain Concussion | 2 | 2021 | 1404 | 0.140 |
Why?
|
Platelet Transfusion | 1 | 2020 | 298 | 0.140 |
Why?
|
Pain, Postoperative | 4 | 2020 | 1740 | 0.140 |
Why?
|
Oncolytic Viruses | 1 | 2021 | 344 | 0.140 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2018 | 110 | 0.140 |
Why?
|
Therapies, Investigational | 1 | 2018 | 111 | 0.140 |
Why?
|
Intermittent Pneumatic Compression Devices | 1 | 2017 | 28 | 0.140 |
Why?
|
Stockings, Compression | 1 | 2017 | 36 | 0.140 |
Why?
|
Bone Transplantation | 1 | 2022 | 929 | 0.140 |
Why?
|
Adenoma, Oxyphilic | 1 | 2018 | 148 | 0.140 |
Why?
|
Pain | 2 | 2023 | 5073 | 0.140 |
Why?
|
Receptor, Notch1 | 1 | 2020 | 496 | 0.140 |
Why?
|
Scalp | 1 | 2020 | 389 | 0.140 |
Why?
|
Tranexamic Acid | 1 | 2019 | 176 | 0.140 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 1 | 2017 | 49 | 0.140 |
Why?
|
Gonadotrophs | 1 | 2016 | 19 | 0.140 |
Why?
|
Databases, Bibliographic | 1 | 2017 | 130 | 0.140 |
Why?
|
Watchful Waiting | 1 | 2021 | 491 | 0.140 |
Why?
|
Body Mass Index | 5 | 2021 | 12953 | 0.140 |
Why?
|
Thyroid Hormones | 1 | 2019 | 404 | 0.140 |
Why?
|
DNA Methylation | 2 | 2021 | 4399 | 0.140 |
Why?
|
Seizures | 4 | 2024 | 2957 | 0.130 |
Why?
|
Triiodothyronine | 1 | 2018 | 493 | 0.130 |
Why?
|
Laminectomy | 2 | 2015 | 225 | 0.130 |
Why?
|
Antifibrinolytic Agents | 1 | 2019 | 292 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3615 | 0.130 |
Why?
|
Netherlands | 2 | 2018 | 2221 | 0.130 |
Why?
|
Orthopedic Procedures | 2 | 2019 | 1265 | 0.130 |
Why?
|
Vitamin K | 1 | 2018 | 318 | 0.130 |
Why?
|
Respiratory System Agents | 1 | 2016 | 30 | 0.130 |
Why?
|
Illinois | 1 | 2016 | 120 | 0.130 |
Why?
|
Aminolevulinic Acid | 1 | 2016 | 144 | 0.130 |
Why?
|
American Civil War | 1 | 2015 | 8 | 0.130 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 491 | 0.130 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 753 | 0.130 |
Why?
|
Verbal Behavior | 1 | 2017 | 335 | 0.130 |
Why?
|
Hyperprolactinemia | 1 | 2016 | 124 | 0.130 |
Why?
|
Oncolytic Virotherapy | 1 | 2021 | 516 | 0.130 |
Why?
|
Radiology | 2 | 2020 | 2113 | 0.130 |
Why?
|
Endocrine Surgical Procedures | 1 | 2015 | 32 | 0.130 |
Why?
|
Body Size | 1 | 2018 | 463 | 0.120 |
Why?
|
Otolaryngology | 1 | 2022 | 693 | 0.120 |
Why?
|
Psychosurgery | 1 | 2015 | 86 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 629 | 0.120 |
Why?
|
Sex Distribution | 2 | 2017 | 2280 | 0.120 |
Why?
|
Remission Induction | 2 | 2021 | 2397 | 0.120 |
Why?
|
Meningitis, Pneumococcal | 1 | 2015 | 43 | 0.120 |
Why?
|
Postoperative Care | 2 | 2018 | 1468 | 0.120 |
Why?
|
Dexamethasone | 2 | 2023 | 1948 | 0.120 |
Why?
|
Hearing Loss | 1 | 2022 | 783 | 0.120 |
Why?
|
Coffee | 1 | 2019 | 593 | 0.120 |
Why?
|
Spinal Fractures | 1 | 2021 | 705 | 0.120 |
Why?
|
Texas | 1 | 2016 | 404 | 0.120 |
Why?
|
Data Mining | 1 | 2020 | 551 | 0.120 |
Why?
|
United States Food and Drug Administration | 1 | 2023 | 1664 | 0.120 |
Why?
|
ABO Blood-Group System | 1 | 2017 | 380 | 0.120 |
Why?
|
Hospitals | 2 | 2020 | 3882 | 0.120 |
Why?
|
Health Priorities | 1 | 2017 | 374 | 0.120 |
Why?
|
Meningoencephalitis | 1 | 2015 | 83 | 0.120 |
Why?
|
Thoracic Vertebrae | 2 | 2016 | 597 | 0.120 |
Why?
|
Famous Persons | 1 | 2015 | 109 | 0.120 |
Why?
|
Osteomyelitis | 1 | 2018 | 407 | 0.120 |
Why?
|
Income | 1 | 2023 | 1877 | 0.120 |
Why?
|
Baseball | 1 | 2015 | 95 | 0.120 |
Why?
|
Hypopituitarism | 1 | 2016 | 250 | 0.120 |
Why?
|
Penicillins | 1 | 2017 | 402 | 0.110 |
Why?
|
Head Protective Devices | 1 | 2015 | 118 | 0.110 |
Why?
|
Cerebrum | 1 | 2015 | 132 | 0.110 |
Why?
|
Recurrence | 5 | 2022 | 8466 | 0.110 |
Why?
|
Age Factors | 7 | 2021 | 18398 | 0.110 |
Why?
|
Fertility | 1 | 2018 | 771 | 0.110 |
Why?
|
Conflict of Interest | 1 | 2019 | 554 | 0.110 |
Why?
|
Cerebral Hemorrhage | 3 | 2023 | 2656 | 0.110 |
Why?
|
Anesthetics, Intravenous | 1 | 2017 | 395 | 0.110 |
Why?
|
Wounds, Nonpenetrating | 1 | 2020 | 807 | 0.110 |
Why?
|
Spinal Cord Injuries | 1 | 2021 | 925 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2019 | 746 | 0.110 |
Why?
|
Medical Records Systems, Computerized | 1 | 2020 | 1192 | 0.110 |
Why?
|
Phenotype | 2 | 2024 | 16592 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12973 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1065 | 0.110 |
Why?
|
Wakefulness | 2 | 2022 | 1265 | 0.110 |
Why?
|
Vena Cava Filters | 2 | 2015 | 261 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1410 | 0.110 |
Why?
|
Serum Albumin | 1 | 2016 | 672 | 0.110 |
Why?
|
Child | 11 | 2023 | 80157 | 0.110 |
Why?
|
Risk Assessment | 7 | 2020 | 23996 | 0.100 |
Why?
|
Hydrocortisone | 1 | 2021 | 1819 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 317 | 0.100 |
Why?
|
Extremities | 1 | 2018 | 867 | 0.100 |
Why?
|
Mucus | 1 | 2014 | 341 | 0.100 |
Why?
|
Neurology | 2 | 2018 | 780 | 0.100 |
Why?
|
Social Behavior | 1 | 2019 | 1135 | 0.100 |
Why?
|
Cerebral Infarction | 1 | 2017 | 983 | 0.100 |
Why?
|
Photosensitizing Agents | 1 | 2016 | 623 | 0.100 |
Why?
|
Cross-Cultural Comparison | 1 | 2015 | 635 | 0.100 |
Why?
|
Patient Education as Topic | 2 | 2019 | 2319 | 0.100 |
Why?
|
Spinal Cord Neoplasms | 1 | 2014 | 263 | 0.100 |
Why?
|
Embolism, Paradoxical | 1 | 2012 | 54 | 0.100 |
Why?
|
Decision Support Techniques | 3 | 2017 | 1998 | 0.100 |
Why?
|
Medical Informatics | 1 | 2019 | 733 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2022 | 4028 | 0.100 |
Why?
|
Suction | 1 | 2013 | 266 | 0.100 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3597 | 0.100 |
Why?
|
Polyradiculopathy | 1 | 2011 | 23 | 0.100 |
Why?
|
International Classification of Diseases | 1 | 2017 | 909 | 0.100 |
Why?
|
Radiotherapy | 1 | 2018 | 1499 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 4063 | 0.090 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2079 | 0.090 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2014 | 485 | 0.090 |
Why?
|
Depression | 1 | 2011 | 8124 | 0.090 |
Why?
|
South Africa | 1 | 2016 | 1843 | 0.090 |
Why?
|
Insurance, Health | 2 | 2020 | 2498 | 0.090 |
Why?
|
Developing Countries | 1 | 2023 | 2885 | 0.090 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5492 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2805 | 0.090 |
Why?
|
Prevalence | 6 | 2023 | 15732 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2020 | 2639 | 0.090 |
Why?
|
Vision Disorders | 1 | 2017 | 1088 | 0.090 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2922 | 0.090 |
Why?
|
Troponin | 1 | 2013 | 502 | 0.090 |
Why?
|
Data Collection | 1 | 2019 | 3322 | 0.090 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12463 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5790 | 0.080 |
Why?
|
Exercise | 2 | 2023 | 5890 | 0.080 |
Why?
|
Causality | 1 | 2016 | 1242 | 0.080 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 730 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11742 | 0.080 |
Why?
|
Immunotherapy, Adoptive | 1 | 2019 | 1469 | 0.080 |
Why?
|
Biopsy | 1 | 2021 | 6766 | 0.080 |
Why?
|
Spinal Cord | 1 | 2017 | 1819 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1668 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7827 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2020 | 1940 | 0.080 |
Why?
|
Posture | 1 | 2013 | 957 | 0.080 |
Why?
|
Medical Oncology | 2 | 2018 | 2321 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1903 | 0.080 |
Why?
|
Public Health | 1 | 2022 | 2669 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3359 | 0.080 |
Why?
|
Checklist | 1 | 2015 | 827 | 0.080 |
Why?
|
Hematoma | 3 | 2018 | 767 | 0.080 |
Why?
|
Pelvis | 1 | 2013 | 733 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1809 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2018 | 2057 | 0.080 |
Why?
|
Hospital Mortality | 3 | 2019 | 5293 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2751 | 0.080 |
Why?
|
Galactorrhea | 2 | 2018 | 23 | 0.080 |
Why?
|
Piperidines | 1 | 2017 | 1656 | 0.080 |
Why?
|
Breast Neoplasms | 3 | 2020 | 21019 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1600 | 0.080 |
Why?
|
Thrombocytopenia | 1 | 2016 | 1182 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20099 | 0.070 |
Why?
|
Fluoroscopy | 1 | 2012 | 947 | 0.070 |
Why?
|
Neural Stem Cells | 1 | 2015 | 888 | 0.070 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 592 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14665 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1852 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2273 | 0.070 |
Why?
|
Memory | 1 | 2017 | 2193 | 0.070 |
Why?
|
Head | 1 | 2013 | 924 | 0.070 |
Why?
|
Dementia | 1 | 2021 | 2689 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3246 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 1516 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2529 | 0.070 |
Why?
|
Cross Infection | 1 | 2015 | 1422 | 0.070 |
Why?
|
Attention | 1 | 2017 | 2396 | 0.070 |
Why?
|
Health Care Reform | 1 | 2015 | 1247 | 0.070 |
Why?
|
Pediatrics | 1 | 2021 | 3589 | 0.070 |
Why?
|
Area Under Curve | 2 | 2022 | 1638 | 0.070 |
Why?
|
Osteoma | 1 | 2005 | 12 | 0.060 |
Why?
|
Blood Loss, Surgical | 2 | 2020 | 638 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3133 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2014 | 6228 | 0.060 |
Why?
|
Europe | 2 | 2023 | 3420 | 0.060 |
Why?
|
Papilloma, Inverted | 1 | 2005 | 19 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1881 | 0.060 |
Why?
|
Preoperative Period | 2 | 2019 | 551 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2164 | 0.060 |
Why?
|
Dura Mater | 2 | 2020 | 290 | 0.060 |
Why?
|
Receptor, erbB-2 | 3 | 2020 | 2557 | 0.060 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2005 | 58 | 0.060 |
Why?
|
Hemangiopericytoma | 1 | 2005 | 71 | 0.060 |
Why?
|
Platelet Count | 2 | 2019 | 781 | 0.060 |
Why?
|
Sex Factors | 2 | 2015 | 10554 | 0.060 |
Why?
|
Angiofibroma | 1 | 2005 | 55 | 0.060 |
Why?
|
Disabled Persons | 1 | 2014 | 1225 | 0.060 |
Why?
|
Bone Screws | 2 | 2020 | 532 | 0.060 |
Why?
|
Skin | 1 | 2018 | 4484 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8553 | 0.060 |
Why?
|
Placebo Effect | 1 | 2008 | 518 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13510 | 0.060 |
Why?
|
Pregnancy | 3 | 2021 | 29876 | 0.060 |
Why?
|
Thiophenes | 1 | 2008 | 569 | 0.060 |
Why?
|
Hemorrhage | 1 | 2015 | 3424 | 0.050 |
Why?
|
Internet | 1 | 2016 | 3093 | 0.050 |
Why?
|
Brain Injuries | 1 | 2015 | 2054 | 0.050 |
Why?
|
History, 20th Century | 3 | 2015 | 2767 | 0.050 |
Why?
|
World Health Organization | 2 | 2020 | 1322 | 0.050 |
Why?
|
Receptors, AMPA | 1 | 2024 | 336 | 0.050 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1277 | 0.050 |
Why?
|
History, 19th Century | 2 | 2015 | 720 | 0.050 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2005 | 262 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2491 | 0.050 |
Why?
|
Retreatment | 1 | 2024 | 598 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2008 | 1440 | 0.050 |
Why?
|
Paranasal Sinus Diseases | 1 | 2002 | 121 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10451 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5315 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2022 | 22176 | 0.050 |
Why?
|
Brain | 3 | 2019 | 27121 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2014 | 3744 | 0.050 |
Why?
|
Fatigue | 1 | 2008 | 1552 | 0.050 |
Why?
|
Vertigo | 1 | 2022 | 202 | 0.050 |
Why?
|
Lithuania | 1 | 2019 | 13 | 0.040 |
Why?
|
Pseudarthrosis | 1 | 2020 | 54 | 0.040 |
Why?
|
Facial Nerve | 1 | 2022 | 277 | 0.040 |
Why?
|
Lumbosacral Region | 1 | 2021 | 293 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2022 | 462 | 0.040 |
Why?
|
Dizziness | 1 | 2022 | 259 | 0.040 |
Why?
|
Child, Preschool | 5 | 2021 | 42231 | 0.040 |
Why?
|
Contraceptives, Oral | 1 | 2022 | 554 | 0.040 |
Why?
|
Gold | 1 | 2023 | 482 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7391 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 8002 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 618 | 0.040 |
Why?
|
Time | 1 | 2020 | 546 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13642 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13382 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2019 | 510 | 0.040 |
Why?
|
Partial Thromboplastin Time | 1 | 2019 | 204 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 250 | 0.040 |
Why?
|
Injury Severity Score | 1 | 2021 | 1045 | 0.040 |
Why?
|
Herpes Simplex | 1 | 2021 | 478 | 0.040 |
Why?
|
Hematocrit | 1 | 2019 | 623 | 0.040 |
Why?
|
Eustachian Tube | 1 | 2018 | 99 | 0.040 |
Why?
|
Automation | 1 | 2020 | 586 | 0.040 |
Why?
|
International Normalized Ratio | 1 | 2019 | 382 | 0.040 |
Why?
|
Hypophysectomy | 1 | 2016 | 114 | 0.030 |
Why?
|
Mortality | 2 | 2018 | 2901 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 362 | 0.030 |
Why?
|
Ownership | 1 | 2019 | 339 | 0.030 |
Why?
|
Methicillin Resistance | 1 | 2017 | 198 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2023 | 1722 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 206 | 0.030 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2018 | 344 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 610 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2016 | 223 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6845 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26127 | 0.030 |
Why?
|
Linear Models | 2 | 2017 | 5872 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 4026 | 0.030 |
Why?
|
Hospital Charges | 1 | 2017 | 350 | 0.030 |
Why?
|
Head Injuries, Penetrating | 1 | 2015 | 28 | 0.030 |
Why?
|
Frail Elderly | 1 | 2020 | 765 | 0.030 |
Why?
|
Hemangioblastoma | 1 | 2015 | 62 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2020 | 1386 | 0.030 |
Why?
|
Cutaneous Fistula | 1 | 2015 | 79 | 0.030 |
Why?
|
Amenorrhea | 1 | 2018 | 483 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1596 | 0.030 |
Why?
|
Health Status | 2 | 2019 | 4077 | 0.030 |
Why?
|
Alberta | 1 | 2014 | 68 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 962 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 2016 | 726 | 0.030 |
Why?
|
Propensity Score | 1 | 2022 | 1913 | 0.030 |
Why?
|
South Carolina | 1 | 2014 | 100 | 0.030 |
Why?
|
Oregon | 1 | 2014 | 148 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2019 | 1129 | 0.030 |
Why?
|
Boston | 2 | 2018 | 9326 | 0.030 |
Why?
|
Epidural Abscess | 1 | 2015 | 94 | 0.030 |
Why?
|
Vancomycin | 1 | 2017 | 503 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 2017 | 3461 | 0.030 |
Why?
|
Perioperative Care | 1 | 2021 | 1036 | 0.030 |
Why?
|
Menopause | 1 | 2022 | 1646 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2017 | 14607 | 0.030 |
Why?
|
Brain Stem Neoplasms | 1 | 2015 | 190 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2020 | 1271 | 0.030 |
Why?
|
Twins, Monozygotic | 1 | 2015 | 470 | 0.030 |
Why?
|
Nervous System Malformations | 1 | 2015 | 244 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1217 | 0.030 |
Why?
|
Disclosure | 1 | 2019 | 748 | 0.030 |
Why?
|
Infant | 3 | 2021 | 36193 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2018 | 1154 | 0.030 |
Why?
|
Homicide | 1 | 2015 | 294 | 0.030 |
Why?
|
Patient Care | 1 | 2018 | 622 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2019 | 860 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2019 | 1301 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2019 | 1768 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2018 | 1264 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2016 | 1336 | 0.020 |
Why?
|
Reference Values | 1 | 2019 | 4920 | 0.020 |
Why?
|
Chicago | 1 | 2012 | 254 | 0.020 |
Why?
|
Syndrome | 1 | 2018 | 3267 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1265 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8633 | 0.020 |
Why?
|
Aftercare | 1 | 2017 | 914 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3578 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4853 | 0.020 |
Why?
|
Urban Population | 1 | 2019 | 2036 | 0.020 |
Why?
|
Sacrum | 1 | 2013 | 276 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2019 | 2209 | 0.020 |
Why?
|
Neck | 1 | 2015 | 734 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4021 | 0.020 |
Why?
|
Cerebellar Neoplasms | 1 | 2015 | 586 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2927 | 0.020 |
Why?
|
Rabbits | 1 | 2016 | 4772 | 0.020 |
Why?
|
California | 1 | 2014 | 1430 | 0.020 |
Why?
|
Thromboembolism | 1 | 2016 | 995 | 0.020 |
Why?
|
Drainage | 1 | 2015 | 1157 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4915 | 0.020 |
Why?
|
Risk Adjustment | 1 | 2013 | 600 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3335 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3123 | 0.020 |
Why?
|
Wounds, Gunshot | 1 | 2015 | 582 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2576 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1457 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2707 | 0.020 |
Why?
|
Rural Population | 1 | 2019 | 2285 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 7054 | 0.020 |
Why?
|
Postural Balance | 1 | 2013 | 622 | 0.020 |
Why?
|
Social Class | 1 | 2017 | 2004 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2811 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 1407 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15502 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6346 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2495 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1792 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3801 | 0.020 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2008 | 186 | 0.020 |
Why?
|
Patient Compliance | 1 | 2017 | 2690 | 0.020 |
Why?
|
Benchmarking | 1 | 2013 | 1045 | 0.020 |
Why?
|
Medicaid | 1 | 2020 | 2818 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2014 | 1836 | 0.020 |
Why?
|
Databases as Topic | 1 | 2008 | 473 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3415 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3905 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6312 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7237 | 0.020 |
Why?
|
Overweight | 1 | 2016 | 2417 | 0.020 |
Why?
|
Anesthesia | 1 | 2015 | 1595 | 0.010 |
Why?
|
Patient Care Team | 1 | 2015 | 2521 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11120 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6241 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2016 | 3188 | 0.010 |
Why?
|
Stem Cells | 1 | 2016 | 3524 | 0.010 |
Why?
|
Recovery of Function | 1 | 2014 | 2979 | 0.010 |
Why?
|
Sphenoid Sinusitis | 1 | 2002 | 10 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4317 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2697 | 0.010 |
Why?
|
Research Design | 1 | 2018 | 6180 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6965 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4811 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5841 | 0.010 |
Why?
|
Analgesics | 1 | 2008 | 1070 | 0.010 |
Why?
|
Electrocardiography | 1 | 2013 | 6377 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15936 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11461 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18255 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26198 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10774 | 0.010 |
Why?
|
Animals | 2 | 2016 | 168475 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 12341 | 0.010 |
Why?
|